Brain Enhancer Modifies Alzheimer’s Disease Progression

The first is focused transcranial magnetic stimulation (TMS), used to stimulate targeted areas of the brain responsible for memory and learning. TMS stimulation induces long-term potentiation (LTP), which is associated with learning and memory processes, making the targeted areas of the brain more receptive to the second modality, Cognitive Training.

The technology creates an atmosphere conducive for TMS and Cognitive Training which together work more effectively than either would alone via a synergistic effect. Patients not only benefit by improvement in cognition, daily activities, and decision-making, they also regain lost skills, and memory restoration is fixated and becomes long lasting. In addition, neuroAD can be used adjunctively with existing medications so patients can take advantage of all treatment options. The neuroAD system is a product of Neuronix Medical (Yoqnea'm, Israel), and has received the European Community CE marking of approval.

“We are not offering a cure, but a way to help patients stay independent and have a better quality of life for longer. It means a lot to them as they can have more time at home and more time to be with their families,” said Eyal Baror, CEO of Neuronix Medical. “The TMS helps to give the brain a boost, much like exercising a muscle. We see the improved cognitive effect lasting for about one year. We have patients returning for their 3rd round of treatment, with excellent results.”

TMS is a noninvasive method to cause depolarization or hyperpolarization in the neurons of the brain via electromagnetic induction that generates weak electric currents using a rapidly changing magnetic field. Studies of the use of TMS to treat many neurological and psychiatric conditions have generally shown only modest effects with little confirmation of results, but appear to be effective in the treatment of certain types of major depression under certain specific conditions.
Related Links

Neuronix Medical